News

At months 6 and 12, tocilizumab retention rates were 94.1% and 86.6%, respectively.

This new research examined trends among adults with severe and recurrent anaphylaxis, and identified several major risk factors.

Granted to Tarsus Pharmaceuticals, the approval of lotilaner ophthalmic solution 0.25% marks the first-and-only FDA-approved therapeutic for Demodex blepharitis, a common eyelid disease.

The American Diabetes Association, together with the American Association of Clinical Chemistry, has released a new, 49-page document outlining optimized guidance for use of laboratory analysis in the diagnosis and management of diabetes.

Data from a phase 1, first-in-human trial of NI006 suggests the agent could have a potential role in the management of transthyretin amyloid cardiomyopathy.

This new research is the first to examine the use of the iMAP milk ladder in primary care settings for younger patients with IgE-mediated cow’s milk protein allergy.

New Study Reveals Efficacy of Bevacizumab in Treating Severe Cases of Pulmonary Papillomatosis.

In the updated analysis, the interleukin-23 p19-subunit inhibitor also showed better skin efficacy.

A cross-sectional analysis suggests disparities in statin use for several race–ethnicity–gender groups were not explained by ASCVD severity or structural factors, including socioeconomic status and health insurance.

Investigators aimed to support extending the US FDA labeling of Xembify to include the biweekly dosing option, therefore, providing greater flexibility and convenience for patients managing their immunodeficiencies.

The risk of mortality was significantly higher in patients with RA treated with JAKs who had not received the COVID-19 vaccine.

Days with a combination of a heat wave and high fine particulate matter air pollution may double the risk of a fatal heart attack, says new research.

New cohort analysis data provide more context into what factors influence the benefit of FMT in patients with recurrent CDI.

This new data highlights the importance of enhancing social connection for older adults and identifying those at greater risk of nursing home entry.

A multipart, phase 1 trial provides evidence demonstrating the safety of zilebesiran, an RNA interference agent, which appeared to have a favorable safety profile among adult patients with hypertension.

A study from China suggests calcium and magnesium malnutrition is associated with Crohn's disease inflammation and activity.

This new research showed the value of physical exercise as well as training to help prevent cognitive declines, although the results had some inconsistencies.

New data presented at the 12th International AIDS Society Conference on HIV Science suggests use of statin therapy in a primary prevention cohort of patients with HIV on antiretroviral therapy was associated with a 35% reduction in risk of cardiovascular events.

The study suggests 1 in every 18 patients would need an MRI scan to detect such significant abnormalities.

Patients who completed the survey were significantly more likely to achieve 12-month persistence on adalimumab biosimilar SB5 when compared with non-respondents.

A combination of baseline factors, early BCVA, and morphologic responses at 3 months only moderately predicted long-term BCVA responses in eyes with nAMD.

Leveraging data from a pair of commercial databases, a new study details the changes in febuxostat prescribing among patients with gout before, during, and after the FDA's addition of a Boxed Warning to prescribing information.

Vogel reviews the struggles behind adequately diagnosing long Covid and quantifying its impact of disease at this time of clinical research.

In this interview with Dr. Baldwin, she spoke on her team’s recent research and its application to rosacea and other dermatologic conditions.

Pediatric rheumatologists were most likely to postpone the decision to withdraw biologic therapy when the patient and/or parents expressed a preference for continuation.

Low vision rehabilitation was associated with statistically significant increases in the overall composite score of a vision-related quality of life scale.

The long-awaited approval for VP-102 makes this treatment the first available therapy for the pox virus-borne skin disease.

The campaign was inspired by the findings of a global survey conducted with healthcare providers about organ damage in lupus patients.

Results show 60% of the children with FASD experienced nightmares, while 44% exhibited frequent insomnia symptoms.

A new analysis suggests Black patients with NICM and an ICD had a high risk and burden of arrhythmia, with a lower survival rate, compared with White patients.